Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02660671
Other study ID # 822504
Secondary ID
Status Completed
Phase N/A
First received January 19, 2016
Last updated May 3, 2017
Start date January 2016
Est. completion date September 2016

Study information

Verified date May 2017
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an RCT aimed at testing different population-based approaches to increasing colorectal cancer screening through email outreach, including usual email communication, active choice, and active choice + financial incentive.


Description:

This is an RCT aimed at testing different population-based approaches to increasing colorectal cancer screening. The investigators will randomize a cohort of employees between the ages of 50-64 to 3 arms of email communications: a.) Usual email communication; b.) Active choice- usual care + the ability to pre-commit directly through a web form; c.) Financial incentive- usual care + active choice + financial incentive for completion.


Recruitment information / eligibility

Status Completed
Enrollment 2250
Est. completion date September 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender All
Age group 50 Years to 64 Years
Eligibility Inclusion Criteria:

- Male and female employees of the University of Pennsylvania Health System who live within 30 miles of a health system endoscopy center.

Study Design


Intervention

Behavioral:
Email outreach
Subjects will receive an email describing the importance of colorectal cancer screening and that s/he has been selected to participate in this VIP concierge service.
Active choice
S/he will receive the ability to pre-commit and choose from 3 different appointment slots by clicking directly on the email.
Financial incentive
The participant will receive the offering of $100 if s/he follows through with screening colonoscopy.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Outcome

Type Measure Description Time frame Safety issue
Primary Colonoscopy participation The percentage of participants who follow through with screening colonoscopy. 3 months
Secondary Email engagement The percentage of participants who respond to the email (arm 2 and 3). 3 months
Secondary Scheduling of colonoscopy The percentage of participants who schedule a procedure. 3 months
See also
  Status Clinical Trial Phase
Completed NCT03068052 - Behavioral Economic Incentives and Cancer Health Risk Assessment N/A
Active, not recruiting NCT03446157 - Palbociclib and Cetuximab in Metastatic Colorectal Cancer Phase 2
Recruiting NCT05955196 - Test of CD47-SIRPĪ± Inhibitors on the Immune Microenvironment Colon Cancer
Completed NCT01287130 - AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Phase 1
Active, not recruiting NCT05179837 - Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps N/A
Completed NCT02929186 - Opt-In Versus Opt-Out for Colorectal Cancer Screening Outreach N/A
Completed NCT03072095 - Colorectal Cancer Screening in a Community Health Setting N/A